{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T01:26:09Z","timestamp":1681694769139},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T00:00:00Z","timestamp":1428710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11030-015-9591-5","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T23:58:19Z","timestamp":1428710299000},"page":"529-539","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase"],"prefix":"10.1007","volume":"19","author":[{"given":"Amaravadhi","family":"Harikishore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam-Joon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Sup","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,11]]},"reference":[{"key":"9591_CR1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nrd4050","volume":"12","author":"MP Manns","year":"2013","unstructured":"Manns MP, von Hahn T (2013) Novel therapies for hepatitis C - one pill fits all? Nat Rev Drug Discov 12:595\u2013610. doi: 10.1038\/nrd4050","journal-title":"Nat Rev Drug Discov"},{"key":"9591_CR2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev-med-042010-085715","volume":"63","author":"DN Fusco","year":"2012","unstructured":"Fusco DN, Chung RT (2012) Novel therapies for hepatitis C: insights from the structure of the virus. Annu Rev Med 63:373\u2013387. doi: 10.1146\/annurev-med-042010-085715","journal-title":"Annu Rev Med"},{"issue":"Suppl 1","key":"9591_CR3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","volume":"29","author":"D Lavanchy","year":"2009","unstructured":"Lavanchy D (2009) The global burden of hepatitis C. Liver Int 29(Suppl 1):74\u201381. doi: 10.1111\/j.1478-3231.2008.01934.x","journal-title":"Liver Int"},{"key":"9591_CR4","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.3748\/wjg.v19.i40.6703","volume":"19","author":"RT Marinho","year":"2013","unstructured":"Marinho RT, Barreira DP (2013) Hepatitis C, stigma and cure. World J Gastroenterol 19:6703\u20136709. doi: 10.3748\/wjg.v19.i40.6703","journal-title":"World J Gastroenterol"},{"key":"9591_CR5","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.3748\/wjg.v18.i42.6060","volume":"18","author":"A Alexopoulou","year":"2012","unstructured":"Alexopoulou A, Papatheodoridis GV (2012) Current progress in the treatment of chronic hepatitis C. World J Gastroenterol 18:6060\u20136069. doi: 10.3748\/wjg.v18.i42.6060","journal-title":"World J Gastroenterol"},{"key":"9591_CR6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrd4036","volume":"12","author":"MT Tse","year":"2013","unstructured":"Tse MT (2013) All-oral HCV therapies near approval. Nat Rev Drug Discov 12:409\u2013411. doi: 10.1038\/nrd4036","journal-title":"Nat Rev Drug Discov"},{"key":"9591_CR7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-pharmtox-011112-140254","volume":"53","author":"JJ Kiser","year":"2013","unstructured":"Kiser JJ, Flexner C (2013) Direct-acting antiviral agents for hepatitis C virus infection. Annu Rev Pharmacol Toxicol 53:427\u2013449. doi: 10.1146\/annurev-pharmtox-011112-140254","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9591_CR8","first-page":"25","volume":"6","author":"E Degasperi","year":"2014","unstructured":"Degasperi E, Aghemo A (2014) Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives. Hepatic Med 6:25\u201333. doi: 10.2147\/HMER.S44375","journal-title":"Hepatic Med"},{"key":"9591_CR9","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/jac\/dkr385","volume":"66","author":"Z Plaza","year":"2011","unstructured":"Plaza Z, Soriano V, Gonzalez Mdel M, Di Lello FA, Macias J, Labarga P, Pineda JA, Poveda E (2011) Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV\/HCV co-infected patients. J Antimicrob Chemother 66:2838\u20132842. doi: 10.1093\/jac\/dkr385","journal-title":"J Antimicrob Chemother"},{"key":"9591_CR10","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0969-2126(00)80031-3","volume":"7","author":"H Ago","year":"1999","unstructured":"Ago H, Adachi T, Yoshida A, Yamamoto M, Habuka N, Yatsunami K, Miyano M (1999) Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Structure 7:1417\u20131426. doi: 10.1016\/S0969-2126(00)80031-3","journal-title":"Structure"},{"key":"9591_CR11","doi-asserted-by":"crossref","first-page":"13034","DOI":"10.1073\/pnas.96.23.13034","volume":"96","author":"S Bressanelli","year":"1999","unstructured":"Bressanelli S, Tomei L, Roussel A, Incitti I, Vitale RL, Mathieu M, De Francesco R, Rey FA (1999) Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci USA 96:13034\u201313039. doi: 10.1073\/pnas.96.23.13034","journal-title":"Proc Natl Acad Sci USA"},{"key":"9591_CR12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/13305","volume":"6","author":"CA Lesburg","year":"1999","unstructured":"Lesburg CA, Cable MB, Ferrari E, Hong Z, Mannarino AF, Weber PC (1999) Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol 6:937\u2013943. doi: 10.1038\/13305","journal-title":"Nat Struct Biol"},{"key":"9591_CR13","doi-asserted-by":"crossref","first-page":"44249","DOI":"10.1074\/jbc.M112.392209","volume":"287","author":"C Rosnoblet","year":"2012","unstructured":"Rosnoblet C, Fritzinger B, Legrand D, Launay H, Wieruszeski JM, Lippens G, Hanoulle X (2012) Hepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5A. J Biol Chem 287:44249\u201344260. doi: 10.1074\/jbc.M112.392209","journal-title":"J Biol Chem"},{"key":"9591_CR14","doi-asserted-by":"crossref","first-page":"e84808","DOI":"10.1371\/journal.pone.0084808","volume":"9","author":"SE Boyce","year":"2014","unstructured":"Boyce SE, Tirunagari N, Niedziela-Majka A, Perry J, Wong M, Kan E, Lagpacan L, Barauskas O, Hung M, Fenaux M, Appleby T, Watkins WJ, Schmitz U, Sakowicz R (2014) Structural and regulatory elements of HCV NS5B polymerase-beta-loop and C-terminal tail-are required for activity of allosteric thumb site II inhibitors. PLoS One 9:e84808. doi: 10.1371\/journal.pone.0084808","journal-title":"PLoS One"},{"key":"9591_CR15","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.bmcl.2008.03.056","volume":"18","author":"SS Antonysamy","year":"2008","unstructured":"Antonysamy SS, Aubol B, Blaney J, Browner MF, Giannetti AM, Harris SF, Hebert N, Hendle J, Hopkins S, Jefferson E, Kissinger C, Leveque V, Marciano D, McGee E, Najera I, Nolan B, Tomimoto M, Torres E, Wright T (2008) Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors. Bioorg Med Chem Lett 18:2990\u20132995. doi: 10.1016\/j.bmcl.2008.03.056","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR16","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1021\/jm3006788","volume":"55","author":"PL Beaulieu","year":"2012","unstructured":"Beaulieu PL, Bos M, Cordingley MG, Chabot C, Fazal G, Garneau M, Gillard JR, Jolicoeur E, LaPlante S, McKercher G, Poirier M, Poupart MA, Tsantrizos YS, Duan J, Kukolj G (2012) Discovery of the first thumb pocket 1 NS5B polymerase inhibitor (BILB 1941) with demonstrated antiviral activity in patients chronically infected with genotype 1 hepatitis C virus (HCV). J Med Chem 55:7650\u20137666. doi: 10.1021\/jm3006788","journal-title":"J Med Chem"},{"key":"9591_CR17","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1016\/j.bmcl.2013.05.037","volume":"23","author":"PL Beaulieu","year":"2013","unstructured":"Beaulieu PL, Coulombe R, Duan J, Fazal G, Godbout C, Hucke O, Jakalian A, Joly MA, Lepage O, Llinas-Brunet M, Naud J, Poirier M, Rioux N, Thavonekham B, Kukolj G, Stammers TA (2013) Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: discovery of a quinazolinone chemotype. Bioorg Med Chem Lett 23:4132\u20134140. doi: 10.1016\/j.bmcl.2013.05.037","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jmb.2006.05.074","volume":"361","author":"BK Biswal","year":"2006","unstructured":"Biswal BK, Wang M, Cherney MM, Chan L, Yannopoulos CG, Bilimoria D, Bedard J, James MN (2006) Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition. J Mol Biol 361:33\u201345. doi: 10.1016\/j.jmb.2006.05.074","journal-title":"J Mol Biol"},{"key":"9591_CR19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bmcl.2003.10.067","volume":"14","author":"L Chan","year":"2004","unstructured":"Chan L, Das SK, Reddy TJ, Poisson C, Proulx M, Pereira O, Courchesne M, Roy C, Wang W, Siddiqui A, Yannopoulos CG, Nguyen-Ba N, Labrecque D, Bethell R, Hamel M, Courtemanche-Asselin P, L\u2019Heureux L, David M, Nicolas O, Brunette S, Bilimoria D, Bedard J (2004) Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides. Bioorg Med Chem Lett 14:793\u2013796. doi: 10.1016\/j.bmcl.2003.10.067","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bmcl.2003.10.068","volume":"14","author":"L Chan","year":"2004","unstructured":"Chan L, Pereira O, Reddy TJ, Das SK, Poisson C, Courchesne M, Proulx M, Siddiqui A, Yannopoulos CG, Nguyen-Ba N, Roy C, Nasturica D, Moinet C, Bethell R, Hamel M, L\u2019Heureux L, David M, Nicolas O, Courtemanche-Asselin P, Brunette S, Bilimoria D, Bedard J (2004) Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides. Bioorg Med Chem Lett 14:797\u2013800. doi: 10.1016\/j.bmcl.2003.10.068","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR21","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1021\/jm0340400","volume":"46","author":"L Chan","year":"2003","unstructured":"Chan L, Reddy TJ, Proulx M, Das SK, Pereira O, Wang W, Siddiqui A, Yannopoulos CG, Poisson C, Turcotte N, Drouin A, Alaoui-Ismaili MH, Bethell R, Hamel M, L\u2019Heureux L, Bilimoria D, Nguyen-Ba N (2003) Identification of N, N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase. J Med Chem 46:1283\u20131285. doi: 10.1021\/jm0340400","journal-title":"J Med Chem"},{"key":"9591_CR22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bmcl.2006.08.104","volume":"17","author":"Y Ding","year":"2007","unstructured":"Ding Y, Smith KL, Varaprasad CV, Chang E, Alexander J, Yao N (2007) Synthesis of thiazolone-based sulfonamides as inhibitors of HCV NS5B polymerase. Bioorg Med Chem Lett 17:841\u2013845. doi: 10.1016\/j.bmcl.2006.08.104","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bmcl.2005.08.114","volume":"16","author":"A Gopalsamy","year":"2006","unstructured":"Gopalsamy A, Aplasca A, Ciszewski G, Park K, Ellingboe JW, Orlowski M, Feld B, Howe AY (2006) Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. Bioorg Med Chem Lett 16:457\u2013460. doi: 10.1016\/j.bmcl.2005.08.114","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR24","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1021\/jm0401255","volume":"47","author":"A Gopalsamy","year":"2004","unstructured":"Gopalsamy A, Lim K, Ciszewski G, Park K, Ellingboe JW, Bloom J, Insaf S, Upeslacis J, Mansour TS, Krishnamurthy G, Damarla M, Pyatski Y, Ho D, Howe AY, Orlowski M, Feld B, O\u2019Connell J (2004) Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors. J Med Chem 47:6603\u20136608. doi: 10.1021\/jm0401255","journal-title":"J Med Chem"},{"key":"9591_CR25","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.bmcl.2006.01.105","volume":"16","author":"A Gopalsamy","year":"2006","unstructured":"Gopalsamy A, Shi M, Ciszewski G, Park K, Ellingboe JW, Orlowski M, Feld B, Howe AY (2006) Design and synthesis of 2,3,4,9-tetrahydro-1H-carbazole and 1,2,3,4-tetrahydro-cyclopenta[b]indole derivatives as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase. Bioorg Med Chem Lett 16:2532\u20132534. doi: 10.1016\/j.bmcl.2006.01.105","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR26","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1016\/j.bmcl.2011.04.052","volume":"21","author":"RW Jackson","year":"2011","unstructured":"Jackson RW, LaPorte MG, Herbertz T, Draper TL, Gaboury JA, Rippin SR, Patel R, Chunduru SK, Benetatos CA, Young DC, Burns CJ, Condon SM (2011) The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase. Bioorg Med Chem Lett 21:3227\u20133231. doi: 10.1016\/j.bmcl.2011.04.052","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR27","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejmech.2013.08.043","volume":"69","author":"I Kucukguzel","year":"2013","unstructured":"Kucukguzel I, Satilmis G, Gurukumar KR, Basu A, Tatar E, Nichols DB, Talele TT, Kaushik-Basu N (2013) 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase. Eur J Med Chem 69:931\u2013941. doi: 10.1016\/j.ejmech.2013.08.043","journal-title":"Eur J Med Chem"},{"key":"9591_CR28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bmcl.2011.11.013","volume":"22","author":"DV Kumar","year":"2012","unstructured":"Kumar DV, Rai R, Brameld KA, Riggs J, Somoza JR, Rajagopalan R, Janc JW, Xia YM, Ton TL, Hu H, Lehoux I, Ho JD, Young WB, Hart B, Green MJ (2012) 3-heterocyclyl quinolone inhibitors of the HCV NS5B polymerase. Bioorg Med Chem Lett 22:300\u2013304. doi: 10.1016\/j.bmcl.2011.11.013","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bmcl.2010.11.068","volume":"21","author":"DV Kumar","year":"2011","unstructured":"Kumar DV, Rai R, Brameld KA, Somoza JR, Rajagopalan R, Janc JW, Xia YM, Ton TL, Shaghafi MB, Hu H, Lehoux I, To N, Young WB, Green MJ (2011) Quinolones as HCV NS5B polymerase inhibitors. Bioorg Med Chem Lett 21:82\u201387. doi: 10.1016\/j.bmcl.2010.11.068","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR30","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.bmcl.2010.03.002","volume":"20","author":"MG LaPorte","year":"2010","unstructured":"LaPorte MG, Draper TL, Miller LE, Blackledge CW, Leister LK, Amparo E, Hussey AR, Young DC, Chunduru SK, Benetatos CA, Rhodes G, Gopalsamy A, Herbertz T, Burns CJ, Condon SM (2010) The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase. Bioorg Med Chem Lett 20:2968\u20132973. doi: 10.1016\/j.bmcl.2010.03.002","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR31","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/cmdc.200800168","volume":"3","author":"MG Laporte","year":"2008","unstructured":"Laporte MG, Jackson RW, Draper TL, Gaboury JA, Galie K, Herbertz T, Hussey AR, Rippin SR, Benetatos CA, Chunduru SK, Christensen JS, Coburn GA, Rizzo CJ, Rhodes G, O\u2019Connell J, Howe AY, Mansour TS, Collett MS, Pevear DC, Young DC, Gao T, Tyrrell DL, Kneteman NM, Burns CJ, Condon SM (2008) The discovery of pyrano[3,4-b]indole-based allosteric inhibitors of HCV NS5B polymerase with in vivo activity. ChemMedChem 3:1508\u20131515. doi: 10.1002\/cmdc.200800168","journal-title":"ChemMedChem"},{"key":"9591_CR32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bmcl.2005.09.047","volume":"16","author":"MG Laporte","year":"2006","unstructured":"Laporte MG, Lessen TA, Leister L, Cebzanov D, Amparo E, Faust C, Ortlip D, Bailey TR, Nitz TJ, Chunduru SK, Young DC, Burns CJ (2006) Tetrahydrobenzothiophene inhibitors of hepatitis C virus NS5B polymerase. Bioorg Med Chem Lett 16:100\u2013103. doi: 10.1016\/j.bmcl.2005.09.047","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR33","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1021\/jm0704447","volume":"50","author":"H Li","year":"2007","unstructured":"Li H, Linton A, Tatlock J, Gonzalez J, Borchardt A, Abreo M, Jewell T, Patel L, Drowns M, Ludlum S, Goble M, Yang M, Blazel J, Rahavendran R, Skor H, Shi S, Lewis C, Fuhrman S (2007) Allosteric inhibitors of hepatitis C polymerase: discovery of potent and orally bioavailable carbon-linked dihydropyrones. J Med Chem 50:3969\u20133972. doi: 10.1021\/jm0704447","journal-title":"J Med Chem"},{"key":"9591_CR34","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1016\/j.bmcl.2006.06.065","volume":"16","author":"H Li","year":"2006","unstructured":"Li H, Tatlock J, Linton A, Gonzalez J, Borchardt A, Dragovich P, Jewell T, Prins T, Zhou R, Blazel J, Parge H, Love R, Hickey M, Doan C, Shi S, Duggal R, Lewis C, Fuhrman S (2006) Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors. Bioorg Med Chem Lett 16:4834\u20134838. doi: 10.1016\/j.bmcl.2006.06.065","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1021\/jm8014537","volume":"52","author":"H Li","year":"2009","unstructured":"Li H, Tatlock J, Linton A, Gonzalez J, Jewell T, Patel L, Ludlum S, Drowns M, Rahavendran SV, Skor H, Hunter R, Shi ST, Herlihy KJ, Parge H, Hickey M, Yu X, Chau F, Nonomiya J, Lewis C (2009) Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]tr iazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor. J Med Chem 52:1255\u20131258. doi: 10.1021\/jm8014537","journal-title":"J Med Chem"},{"key":"9591_CR36","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.bmc.2010.03.024","volume":"18","author":"S Malancona","year":"2010","unstructured":"Malancona S, Donghi M, Ferrara M, Martin Hernando JI, Pompei M, Pesci S, Ontoria JM, Koch U, Rowley M, Summa V (2010) Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates. Bioorg Med Chem 18:2836\u20132848. doi: 10.1016\/j.bmc.2010.03.024","journal-title":"Bioorg Med Chem"},{"key":"9591_CR37","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1021\/jm401362f","volume":"57","author":"G Manfroni","year":"2014","unstructured":"Manfroni G, Cannalire R, Barreca ML, Kaushik-Basu N, Leyssen P, Winquist J, Iraci N, Manvar D, Paeshuyse J, Guhamazumder R, Basu A, Sabatini S, Tabarrini O, Danielson UH, Neyts J, Cecchetti V (2014) The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors. J Med Chem 57:1952\u20131963. doi: 10.1021\/jm401362f","journal-title":"J Med Chem"},{"key":"9591_CR38","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1021\/jm900517t","volume":"52","author":"JM Ontoria","year":"2009","unstructured":"Ontoria JM, Rydberg EH, Di Marco S, Tomei L, Attenni B, Malancona S, Martin Hernando JI, Gennari N, Koch U, Narjes F, Rowley M, Summa V, Carroll SS, Olsen DB, De Francesco R, Altamura S, Migliaccio G, Carfi A (2009) Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors. J Med Chem 52:5217\u20135227. doi: 10.1021\/jm900517t","journal-title":"J Med Chem"},{"key":"9591_CR39","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/S0960-894X(03)00670-X","volume":"13","author":"TJ Reddy","year":"2003","unstructured":"Reddy TJ, Chan L, Turcotte N, Proulx M, Pereira OZ, Das SK, Siddiqui A, Wang W, Poisson C, Yannopoulos CG, Bilimoria D, L\u2019Heureux L, Alaoui HM, Nguyen-Ba N (2003) Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase. Bioorg Med Chem Lett 13:3341\u20133344. doi: 10.1016\/S0960-894X(03)00670-X","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR40","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1016\/j.bmcl.2013.09.102","volume":"23","author":"TA Stammers","year":"2013","unstructured":"Stammers TA, Coulombe R, Duplessis M, Fazal G, Gagnon A, Garneau M, Goulet S, Jakalian A, LaPlante S, Rancourt J, Thavonekham B, Wernic D, Kukolj G, Beaulieu PL (2013) Anthranilic acid-based thumb pocket 2 HCV NS5B polymerase inhibitors with sub-micromolar potency in the cell-based replicon assay. Bioorg Med Chem Lett 23:6879\u20136885. doi: 10.1016\/j.bmcl.2013.09.102","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR41","doi-asserted-by":"crossref","unstructured":"Stammers TA, Coulombe R, Rancourt J, Thavonekham B, Fazal G, Goulet S, Jakalian A, Wernic D, Tsantrizos Y, Poupart MA, Bos M, McKercher G, Thauvette L, Kukolj G, Beaulieu PL (2013) Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors. Bioorg Med Chem Lett 23:2585\u20132589. doi: 10.1016\/j.bmcl.2013.02.110","DOI":"10.1016\/j.bmcl.2013.02.110"},{"key":"9591_CR42","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.bmcl.2007.01.024","volume":"17","author":"S Yan","year":"2007","unstructured":"Yan S, Appleby T, Larson G, Wu JZ, Hamatake RK, Hong Z, Yao N (2007) Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study. Bioorg Med Chem Lett 17:1991\u20131995. doi: 10.1016\/j.bmcl.2007.01.024","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bmcl.2006.09.095","volume":"17","author":"S Yan","year":"2007","unstructured":"Yan S, Larson G, Wu JZ, Appleby T, Ding Y, Hamatake R, Hong Z, Yao N (2007) Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure. Bioorg Med Chem Lett 17:63\u201367. doi: 10.1016\/j.bmcl.2006.09.095","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR44","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1016\/j.bmcl.2010.06.008","volume":"20","author":"H Yang","year":"2010","unstructured":"Yang H, Hendricks RT, Arora N, Nitzan D, Yee C, Lucas MC, Yang Y, Fung A, Rajyaguru S, Harris SF, Leveque VJ, Hang JQ, Pogam SL, Reuter D, Tavares GA (2010) Cyclic amide bioisosterism: strategic application to the design and synthesis of HCV NS5B polymerase inhibitors. Bioorg Med Chem Lett 20:4614\u20134619. doi: 10.1016\/j.bmcl.2010.06.008","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR45","unstructured":"Accelrys (2007) Discovery Studio Modeling Environment, Release 3.5 Accelrys Software Inc, San Diego"},{"key":"9591_CR46","unstructured":"Accelrys Draw. Accelrys Software Inc, San Diego"},{"key":"9591_CR47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jcc.540160205","volume":"16","author":"A Smellie","year":"1995","unstructured":"Smellie A, Teig SL, Towbin P (1995) Poling: promoting conformational variation. J Comput Chem 16:171\u2013187. doi: 10.1002\/jcc.540160205","journal-title":"J Comput Chem"},{"key":"9591_CR48","doi-asserted-by":"crossref","unstructured":"Guner OF (2000) Pharmacophore Perception, Development, and Use in Drug Design (Iul Biotechnology Series, 2). International University Line, La Jolla. doi: 10.3390\/50700987","DOI":"10.3390\/50700987"},{"key":"9591_CR49","unstructured":"ChemDiv, 6605 Nancy Ridge Dr, San Diego, CA 92121. www.chemdiv.com"},{"key":"9591_CR50","unstructured":"InterBioScreen 119019 Moscow. www.ibscreen.com\/indexhtm"},{"key":"9591_CR51","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1016\/j.bmcl.2012.05.025","volume":"22","author":"E Canales","year":"2012","unstructured":"Canales E, Carlson JS, Appleby T, Fenaux M, Lee J, Tian Y, Tirunagari N, Wong M, Watkins WJ (2012) Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors. Bioorg Med Chem Lett 22:4288\u20134292. doi: 10.1016\/j.bmcl.2012.05.025","journal-title":"Bioorg Med Chem Lett"},{"key":"9591_CR52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-2836(95)80037-9","volume":"245","author":"G Jones","year":"1995","unstructured":"Jones G, Willett P, Glen RC (1995) Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol Biol 245:43\u201353. doi: 10.1016\/S0022-2836(95)80037-9","journal-title":"J Mol Biol"},{"key":"9591_CR53","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727\u2013748. doi: 10.1006\/jmbi.1996.0897","journal-title":"J Mol Biol"},{"key":"9591_CR54","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","volume":"290","author":"KJ Blight","year":"2000","unstructured":"Blight KJ, Kolykhalov AA, Rice CM (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290:1972\u20131974. doi: 10.1126\/science.290.5498.1972","journal-title":"Science"},{"key":"9591_CR55","unstructured":"Nonlinear regression with Dose response inhibition model was performed using GraphPad Prism version 5.00 for Windows. GraphPad Software, 7825 Fay Ave #230, La Jolla, CA 92037. www.graphpad.com"},{"key":"9591_CR56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.antiviral.2014.01.006","volume":"104","author":"W Xue","year":"2014","unstructured":"Xue W, Jiao P, Liu H, Yao X (2014) Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598. Antivir Res 104:40\u201351. doi: 10.1016\/j.antiviral.2014.01.006","journal-title":"Antivir Res"},{"key":"9591_CR57","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejmech.2012.09.010","volume":"58","author":"AG Golub","year":"2012","unstructured":"Golub AG, Gurukumar KR, Basu A, Bdzhola VG, Bilokin Y, Yarmoluk SM, Lee JC, Talele TT, Nichols DB, Kaushik-Basu N (2012) Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors. Eur J Med Chem 58:258\u2013264. doi: 10.1016\/j.ejmech.2012.09.010","journal-title":"Eur J Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-015-9591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-015-9591-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-015-9591-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:58:31Z","timestamp":1559357911000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-015-9591-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,11]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["9591"],"URL":"https:\/\/doi.org\/10.1007\/s11030-015-9591-5","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,11]]}}}